Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2018

Open Access 01-12-2018 | Case report

Coexistence of medullary thyroid carcinoma and recurrent non-functional pituitary adenoma: a case report

Authors: Mohammad Bagherzadeh, Arya Aminorroaya, Jamshid Vafaeimanesh, Mohammad Reza Mohajeri-Tehrani

Published in: Journal of Medical Case Reports | Issue 1/2018

Login to get access

Abstract

Background

Medullary thyroid carcinoma and pituitary adenoma are neuroendocrine tumors and their coexistence has not been reported in the literature, previously. Medullary thyroid carcinoma is a neoplasm of the thyroid gland arising from parafollicular c-cells producing calcitonin, and pituitary adenoma is a benign hyperplasia of the cells of the pituitary gland. Coexistence of these neoplasms can be explained by being affected by simultaneous primary neoplasms or tumor-to-tumor metastasis phenomenon.

Case presentation

We present the case of a 60-year-old Persian man who presented to the clinic with a chief complaint of headache for the last 2 months. His past medical history was significant for non-functional pituitary macroadenoma and medullary thyroid carcinoma and he had received a total thyroidectomy and a transsphenoidal surgery several years ago. Diagnostic evaluations revealed that the pituitary adenoma has recurred. He was well and symptom-free after the second transsphenoidal surgery for resection of the adenoma. Noticeably, investigations were negative for any form of multiple endocrine neoplasia syndromes; however, we could not rule them out definitively.

Conclusions

To the best of our knowledge, it is the first case reported in the literature of a patient who has been affected by recurrent non-functional pituitary adenoma and medullary thyroid carcinoma, concomitantly. Although this association can be accidental, it emphasizes the fact that patients with a history of a neoplasm should be monitored regularly in order to diagnose and treat possible second primary cancers in a timely manner. Of note, this consideration is of great importance in patients whose first neoplasms have better prognosis and survival rates, which provide them more time to develop second primary cancers, for example, pituitary adenoma.
Literature
1.
go back to reference Spielman DB, Badhey A, Kadakia S, Inman JC, Ducic Y. Rare thyroid malignancies: an overview for the oncologist. Clin Oncol (R Coll Radiol). 2017;29(5):298–306.CrossRef Spielman DB, Badhey A, Kadakia S, Inman JC, Ducic Y. Rare thyroid malignancies: an overview for the oncologist. Clin Oncol (R Coll Radiol). 2017;29(5):298–306.CrossRef
2.
go back to reference Theodros D, Patel M, Ruzevick J, Lim M, Bettegowda C. Pituitary adenomas: historical perspective, surgical management and future directions. CNS Oncology. 2015;4(6):411–29.CrossRefPubMedPubMedCentral Theodros D, Patel M, Ruzevick J, Lim M, Bettegowda C. Pituitary adenomas: historical perspective, surgical management and future directions. CNS Oncology. 2015;4(6):411–29.CrossRefPubMedPubMedCentral
3.
go back to reference Roelfsema F, Biermasz NR, Pereira AM. Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary. 2012;15(1):71–83.CrossRefPubMed Roelfsema F, Biermasz NR, Pereira AM. Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary. 2012;15(1):71–83.CrossRefPubMed
4.
go back to reference Saito T, Miura D, Taguchi M, Takeshita A, Miyakawa M, Takeuchi Y. Coincidence of multiple endocrine neoplasia type 2A with acromegaly. Am J Med Sci. 2010;340(4):329–31.CrossRefPubMed Saito T, Miura D, Taguchi M, Takeshita A, Miyakawa M, Takeuchi Y. Coincidence of multiple endocrine neoplasia type 2A with acromegaly. Am J Med Sci. 2010;340(4):329–31.CrossRefPubMed
5.
go back to reference Bhatoe HS, Badwal S, Dutta V, Kannan N. Pituitary metastasis from medullary carcinoma of thyroid: case report and review of literature. J Neuro-Oncol. 2008;89(1):63–7.CrossRef Bhatoe HS, Badwal S, Dutta V, Kannan N. Pituitary metastasis from medullary carcinoma of thyroid: case report and review of literature. J Neuro-Oncol. 2008;89(1):63–7.CrossRef
6.
go back to reference Williams MD, Asa SL, Fuller GN. Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis. Ann Diagn Pathol. 2008;12(3):199–203.CrossRefPubMed Williams MD, Asa SL, Fuller GN. Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis. Ann Diagn Pathol. 2008;12(3):199–203.CrossRefPubMed
7.
go back to reference Lim W, Lim DS, Chng CL, Lim AY. Thyroid carcinoma with pituitary metastases: 2 case reports and literature review. Case Rep Endocrinol. 2015;2015:252157.PubMedPubMedCentral Lim W, Lim DS, Chng CL, Lim AY. Thyroid carcinoma with pituitary metastases: 2 case reports and literature review. Case Rep Endocrinol. 2015;2015:252157.PubMedPubMedCentral
8.
go back to reference Heinlen JE, Buethe DD, Culkin DJ, Slobodov G. Multiple endocrine neoplasia 2a presenting with pheochromocytoma and pituitary macroadenoma. ISRN Oncology. 2011;2011:732452.CrossRefPubMedPubMedCentral Heinlen JE, Buethe DD, Culkin DJ, Slobodov G. Multiple endocrine neoplasia 2a presenting with pheochromocytoma and pituitary macroadenoma. ISRN Oncology. 2011;2011:732452.CrossRefPubMedPubMedCentral
9.
go back to reference Gejman R, Swearingen B, Hedley-Whyte ET. Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Hum Pathol. 2008;39(5):758–66.CrossRefPubMed Gejman R, Swearingen B, Hedley-Whyte ET. Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Hum Pathol. 2008;39(5):758–66.CrossRefPubMed
10.
go back to reference Steno A, Bocko J, Rychly B, Chorvath M, Celec P, Fabian M, Belan V, Steno J. Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth. Acta Neurochir. 2014;156(3):451–61. discussion 461CrossRefPubMed Steno A, Bocko J, Rychly B, Chorvath M, Celec P, Fabian M, Belan V, Steno J. Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth. Acta Neurochir. 2014;156(3):451–61. discussion 461CrossRefPubMed
Metadata
Title
Coexistence of medullary thyroid carcinoma and recurrent non-functional pituitary adenoma: a case report
Authors
Mohammad Bagherzadeh
Arya Aminorroaya
Jamshid Vafaeimanesh
Mohammad Reza Mohajeri-Tehrani
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2018
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-018-1745-5

Other articles of this Issue 1/2018

Journal of Medical Case Reports 1/2018 Go to the issue